Free Trial

Healthpeak Properties (DOC) Stock Forecast & Price Target

$19.13
-0.25 (-1.29%)
(As of 03:28 PM ET)

Healthpeak Properties - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$19.41
1.46% Upside
High Forecast$25.00
Average Forecast$19.41
Low Forecast$14.00
TypeCurrent Forecast
6/22/23 to 6/21/24
1 Month Ago
5/23/23 to 5/22/24
3 Months Ago
3/24/23 to 3/23/24
1 Year Ago
6/22/22 to 6/22/23
Consensus Rating
Moderate Buy
Moderate Buy
Hold
Hold
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
8 Buy rating(s)
3 Buy rating(s)
4 Buy rating(s)
Hold
6 Hold rating(s)
6 Hold rating(s)
5 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$19.41$19.08$16.00$16.85
Forecasted Upside1.46% Upside14.02% Upside11.52% Upside9.73% Upside
Get Healthpeak Properties Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for DOC and its competitors with MarketBeat's FREE daily newsletter.

DOC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

DOC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Healthpeak Properties Stock vs. The Competition

TypeHealthpeak PropertiesFinance CompaniesS&P 500
Consensus Rating Score
2.64
2.43
2.50
Consensus RatingModerate BuyHoldHold
Predicted Upside0.10% Upside62.94% Upside11.13% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/16/2024Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Outperform ➝ Sector Outperform$22.00 ➝ $23.00+14.14%
5/16/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$19.00 ➝ $21.00+3.70%
5/9/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Ferguson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/3/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Anderson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform
4/26/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Outperform$19.00 ➝ $21.00+11.94%
4/22/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy$22.00+22.36%
4/10/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$21.00 ➝ $22.00+13.75%
4/1/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Buy$18.00 ➝ $25.00+33.33%
3/25/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageEqual Weight$19.00+8.32%
1/5/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Sector Weight
1/2/2024Compass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$19.00 ➝ $18.00+35.75%
12/22/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold ➝ Hold$15.00 ➝ $14.00+5.74%
8/22/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$15.00 ➝ $14.00+4.40%
7/20/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$14.50-1.16%
5/26/2023JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$15.50+14.81%
5/5/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$18.00 ➝ $17.00+17.73%
3/29/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingNeutral$15.00+2.88%
8/5/2022Colliers Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Toti
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$19.00+10.59%
6/30/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$21.00 ➝ $20.00+13.31%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 03:55 PM ET.

DOC Forecast - Frequently Asked Questions

What is Healthpeak Properties's stock forecast and purchase recommendation?

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Healthpeak Properties is $19.41, with a high forecast of $25.00 and a low forecast of $14.00. The consensus rating for Healthpeak Properties stock is Moderate Buy based on the current 6 hold ratings, 7 buy ratings and 1 strong buy rating for DOC. Learn more on DOC's analyst rating history.

Do Wall Street analysts like Healthpeak Properties more than its competitors?

Analysts like Healthpeak Properties more than other "finance" companies. The consensus rating for Healthpeak Properties is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how DOC compares to other companies.

Is Healthpeak Properties being upgraded by Wall Street analysts?

Over the previous 90 days, Healthpeak Properties's stock had 4 upgrades by analysts.

Does Healthpeak Properties's stock price have much upside?

According to analysts, Healthpeak Properties's stock has a predicted upside of 13.96% based on their 12-month stock forecasts.

What analysts cover Healthpeak Properties?

Healthpeak Properties has been rated by research analysts at Argus, Bank of America, BNP Paribas, JPMorgan Chase & Co., Mizuho, Royal Bank of Canada, Scotiabank, Wedbush, and Wells Fargo & Company in the past 90 days.


Stock Forecasts and Research Tools

This page (NYSE:DOC) was last updated on 6/21/2024 by MarketBeat.com Staff

From Our Partners